Back to Search
Start Over
The role of pharmacological stress testing in women.
- Source :
-
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology [J Nucl Cardiol] 2016 Oct; Vol. 23 (5), pp. 997-1007. Date of Electronic Publication: 2016 Aug 11. - Publication Year :
- 2016
-
Abstract
- Pharmacological stress is an alternative method to dynamic exercise that combined with noninvasive imaging allows the detection of flow-limiting coronary artery disease (CAD). It represents the stress procedure of choice in patients who cannot exercise appropriately. In women, pharmacological stress combined with myocardial perfusion scintigraphy (MPS) has demonstrated to be highly accurate for the detection of obstructive CAD and a valuable tool that helps separate patients at low cardiac risk from those with an adverse prognosis. Pharmacological stress with positron emission tomographic (PET) imaging is increasingly used in the investigation of suspected obstructive CAD; available evidence shows that the diagnostic profile and prognostic value of stress PET imaging is similar to that of stress MPS in women.
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Evidence-Based Medicine
Female
Humans
Middle Aged
Prognosis
Reproducibility of Results
Sensitivity and Specificity
Women's Health
Young Adult
Coronary Artery Disease diagnostic imaging
Exercise Test methods
Image Enhancement methods
Myocardial Ischemia diagnostic imaging
Myocardial Perfusion Imaging methods
Positron-Emission Tomography methods
Vasodilator Agents
Subjects
Details
- Language :
- English
- ISSN :
- 1532-6551
- Volume :
- 23
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 27515346
- Full Text :
- https://doi.org/10.1007/s12350-016-0602-4